![OIS XIV - Web Banner 2024 -3 copy OIS XIV - Web Banner 2024 -3 copy](https://ois.net/wp-content/uploads/2024/05/OIS-XIV-Web-Banner-2024-3-copy.png)
Friday | November 22, 2024 - AGENDA
9:00 - 12:00 PM
Morning Startup bootcamp
11:45 - 12:30 PM
Check-in and Networking Lunch
12:35 - 12:40 PM
Welcome & Opening Remarks
12:40 - 1:40 PM
New Innovation Showcase
1:40 - 2:40 PM
Town Hall With CCIO
Moderated by:
Malvina Eydelman, MD
2:40 - 3:10 PM
How to Tackle Functional Endpoints in a Dry AMD study
3:10 - 3:45 PM
Afternoon Networking Break
3:45 - 4:25 PM
Investor Strategy
Understanding your investors and your investment strategies.
Moderated by:
Paul Bresge, CEO - Ray Therapeutics
4:25 - 4:55 PM
Myopia Management
4:55 - 6:00 PM
Spotlight on Cell and Gene Therapy
6:00 - 7:30 PM
Networking Reception
Saturday | November 23, 2024 - AGENDA
7:30 - 8:30 AM
Networking Breakfast & Check-In
8:30 - 8:50 AM
Closing out 2024
8:50 - 10:10 AM
Anterior Innovation Showcase
10:10 - 10:40 AM
Anterior Innovation: A Panel of Disruptors and Visionaries
Moderated by:
Anthony Wallace, Vice President & General Manager - Bausch + Lomb
10:40 - 11:15 AM
Morning Networking Break
11:15 - 11:45 AM
AI in Ophthamology
11:45 - 1:00 PM
Retina Innovation Showcase
1:00 - 1:50 PM
Networking Lunch
1:50 - 2:50 PM
Spotlight on Suprachoroidal Drug Delivery
Overview
Company Presentations
Expert Panel Discussion
Panelists:
Robert B. Bhisitkul, MD, PhD, Professor of Ophthalmology - University of California San Francisco School of Medicine
Co-Moderated By:
Thomas A. Ciulla, MD, MBA, FASRS, Clinical Professor of Ophthalmology, Volunteer/Vitreoretinal Medicine and Surgery
Indiana University School of Medicine / Midwest Eye Institute
Emmett T. Cunningham Jr., MD, PhD, MPH, Executive Chairman - Eyconis / Senior Partner - HealthQuest Capital Management
2:50 - 3:20 PM
Spotlight on Glaucoma - Standard of Care vs. Innovation
3:20 - 3:50 PM
TBD
3:50 - 4:20 PM
Networking Break
4:20 - 5:00 PM
Reverse Pitch by Strategics
5:00 - 5:30 PM
A View from the Street
Panelists:
Anupam Dalal, MD, Chief Investment Officer and Managing Member - Acuta Capital Partners
Andrew Gitkin, Senior Managing Director, Healthcare – Leerink Partners
Cameron Taylor, Managing Director - BofA Securities | Life Sciences
Moderated By:
Pravin U. Dugel, MD, President, CEO & Executive Chairman - Ocular Therapeutix
5:30 - 7:00 PM